News
antibody-drug conjugate (ADC) for the treatment of extensive-stage small cell lung cancer (ES-SCLC), will be presented during a poster session at the 2025 American Society of Clinical Oncology (ASCO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback